Seer is changing the arc of proteomics

Backed by decades of research in nanoparticles, the nano-bio interface, machine learning, and systems biology, our Proteograph® Product Suite accelerates breakthroughs to overcome the challenges of complex biological matrices and low-abundance targets to deliver the increased depth, accuracy, and scalability needed to drive breakthroughs in drug development, disease research, and precision medicine.

Key Milestones in the Evolution of Proteomics

The progression of scale, depth, and scientific impact

1999

1st PubMed mention of Human Proteome Project

2001

HUPO founded, HPPP launched

2015

Deepest study (16 samples; 5,300 proteins)

2017

Seer founded

2019

Largest study (48 samples; 1,835 proteins)

2020

Seer study of 141 samples; 2,500 proteins
First Proteograph shipped to customer

2022

Multiple studies of > 1,000 samples completed Deepest customer study > 6,000 proteins

2023

PrognomiQ 15,000 samples completed Deepest customer study > 6,000 proteins

2025

20,000-sample population study

What is a nanoparticle (NP)?

A nanoparticle (NP) is usually defined as a particle that is less than 500 nanometers in diameter (significantly smaller than a particle). NPs have been used in a wide range of diverse applications, including medicine (nanomedicine), biotechnology and pharmaceuticals, energy, electronics and communications, automobiles/machinery, chemistry and materials, and environmental testing.

Start your project with Seer

Request more info

How do nanoparticles behave in a biological medium?

When nanoparticles are placed in contact with a biological sample, a thin layer of intact proteins rapidly, selectively, and reproducibly absorb onto the surface of a nanoparticle upon contact, forming what is called a protein “corona”.

Start your project with Seer

Request more info

Can nanoparticles be tuned to modify the composition of the protein corona?

The composition and quantity of the corona proteins depend on the 
physicochemical properties of the NPs and the surface. Properties like nanoparticle size, shape, material, charge, porosity, as well as surface functional groups will 
impact corona composition.

Start your project with Seer

Request more info

How do nanoparticles enable broad and deep coverage of the plasma proteome?

When nanoparticles come into contact with proteins in a biofluid, based on the nanoparticles’ tuned physicochemical properties, a highly reproducible and robust protein corona will form containing proteins spanning the wide dynamic range of the plasma proteome. The dynamic range is quantitatively compressed as a function of relative affinities and protein concentrations. With the use of a panel of several diverse nanoparticles, the resulting protein coronas will cumulatively result in broad and deep coverage of the plasma proteome.

Start your project with Seer

Request more info

What makes Seer’s engineered nanoparticles unique? 

What are they used for?

Seer’s engineered nanoparticles (NPs) consist of a magnetic core and a surface with unique physicochemical properties. When nanoparticles are introduced into a biofluid, such as blood plasma, a selective and reproducible protein corona is formed at the nano-bio interface, driven by a combination of protein-nanoparticle affinity, protein abundance, and protein-protein interactions.
Panels of these proprietary engineered NPs have been designed to efficiently and robustly sample the physicochemical space of the entire proteome, compressing the dynamic range quantitatively to render biological information more accessible for any downstream detector.

Start your project with Seer

Request more info

The promise of proteomics, now in full view

All tech notes

Starting your proteomics research is effortless

Connect with an expert to discuss which path to the full proteome is right for you.

  1. Bring the Proteograph Product Suite in-house
  2. Run a project with
    Seer Technology
    Access Center
  3. Conduct a project with
    a Seer service provider
    or Center of Excellence